EP2046342A4 - Kristalline form a von ibandronsäure und herstellungsverfahren dafür - Google Patents

Kristalline form a von ibandronsäure und herstellungsverfahren dafür

Info

Publication number
EP2046342A4
EP2046342A4 EP07813544A EP07813544A EP2046342A4 EP 2046342 A4 EP2046342 A4 EP 2046342A4 EP 07813544 A EP07813544 A EP 07813544A EP 07813544 A EP07813544 A EP 07813544A EP 2046342 A4 EP2046342 A4 EP 2046342A4
Authority
EP
European Patent Office
Prior art keywords
preparation
crystalline form
ibandronic acid
ibandronic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07813544A
Other languages
English (en)
French (fr)
Other versions
EP2046342A2 (de
Inventor
Vijayabhaskar Bolugoddu
Jaydeepkumar Lilakar Dahyabhai
Rambabu Venkata Kammili
Yogesh Prakash More
Pallavi Thakur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of EP2046342A2 publication Critical patent/EP2046342A2/de
Publication of EP2046342A4 publication Critical patent/EP2046342A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP07813544A 2006-07-28 2007-07-30 Kristalline form a von ibandronsäure und herstellungsverfahren dafür Withdrawn EP2046342A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82063806P 2006-07-28 2006-07-28
PCT/US2007/074738 WO2008014510A2 (en) 2006-07-28 2007-07-30 Crystalline form a of ibandronic acid and process for the preparation

Publications (2)

Publication Number Publication Date
EP2046342A2 EP2046342A2 (de) 2009-04-15
EP2046342A4 true EP2046342A4 (de) 2011-05-04

Family

ID=38982427

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07813544A Withdrawn EP2046342A4 (de) 2006-07-28 2007-07-30 Kristalline form a von ibandronsäure und herstellungsverfahren dafür

Country Status (2)

Country Link
EP (1) EP2046342A4 (de)
WO (1) WO2008014510A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008242788A1 (en) * 2007-04-19 2008-10-30 Dr. Reddy's Laboratories Ltd. Ibandronate sodium polymorphs
WO2009042179A1 (en) * 2007-09-24 2009-04-02 Teva Pharmaceutical Industries Ltd. Crystalline forms of ibandronic acid and processeses for the preparation thereof
WO2012007021A1 (en) * 2010-07-14 2012-01-19 Pharmathen S.A. Process for the preparation of 3-(n-methyl-n-pentyl)amino-1-hydroxypropane-1,1-diphosphonic acid salt or derivatives thereof
TR201200588A2 (tr) * 2012-01-18 2012-07-23 Koçak Farma İlaç Ve Ki̇mya Sanayi̇ Anoni̇m Şi̇rketi̇ Sodyum ibandronat monohidrat polimorflarini ve polimorflu karışımlarını hazırlamak için prosesler.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063779A2 (en) * 2003-12-23 2005-07-14 Lyogen Limited A process for the preparation of alkyl- and aryl-diphosphonic acids and salts thereof
WO2006002348A2 (en) * 2004-06-23 2006-01-05 Teva Pharmaceutical Industies Ltd. Solid and crystalline ibandronic acid
WO2006024024A2 (en) * 2004-08-23 2006-03-02 Teva Pharmaceutical Industries Ltd. Solid and crystalline ibandronate sodium and processes for preparation thereof
WO2006045578A2 (en) * 2004-10-29 2006-05-04 F. Hoffmann-La Roche Ag Process for the preparation of ibandronate
WO2007074475A2 (en) * 2005-12-27 2007-07-05 Natco Pharma Limited Novel polymorphic forms of ibandronate

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063779A2 (en) * 2003-12-23 2005-07-14 Lyogen Limited A process for the preparation of alkyl- and aryl-diphosphonic acids and salts thereof
WO2006002348A2 (en) * 2004-06-23 2006-01-05 Teva Pharmaceutical Industies Ltd. Solid and crystalline ibandronic acid
WO2006024024A2 (en) * 2004-08-23 2006-03-02 Teva Pharmaceutical Industries Ltd. Solid and crystalline ibandronate sodium and processes for preparation thereof
WO2006045578A2 (en) * 2004-10-29 2006-05-04 F. Hoffmann-La Roche Ag Process for the preparation of ibandronate
WO2007074475A2 (en) * 2005-12-27 2007-07-05 Natco Pharma Limited Novel polymorphic forms of ibandronate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CAIRA M R: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, ISBN: 978-3-540-36760-4, DOI: 10.1007/3-540-69178-2_5 *
DING C Z ET AL: "Transformation of monoamine oxidase-B primary amine substrates into time- dependent inhibitors. Tertiary amine homologues of primary amine substrates", JOURNAL OF MEDICINAL CHEMISTRY 1993 US, vol. 36, no. 12, 1993, pages 1711 - 1715, XP002629189, ISSN: 0022-2623 *

Also Published As

Publication number Publication date
WO2008014510A3 (en) 2008-11-20
EP2046342A2 (de) 2009-04-15
WO2008014510A2 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
ZA200904311B (en) Process for preparing 5-biphenyl-4-amino-2 methyl pentanoic acid
IL196234A0 (en) A process for the preparation of optically active cyclopropylamines
IL194522A0 (en) Process for the preparation of prasugrel
ZA200800729B (en) A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it
IL198330A0 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
ZA200903533B (en) Process for the preparation of rosuvastatin
ZA201007625B (en) Crystalline form of tenofovir disoproxil and a process for its preparation
EP2035410A4 (de) Neues verfahren zur herstellung von esomeprazol und salzen davon
ZA200905601B (en) Improved process for the preparation of ozidized phospholipids
PL2016045T3 (pl) Krystaliczna postać tygecykliny i sposoby jej otrzymywania
PL2137206T3 (pl) Sposób wytwarzania kwasu tauroursodeoksycholowego
IL198388A0 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
SI2220152T1 (sl) Postopek za pripravo sestavka premreĹľevalnega sredstva
ZA200907191B (en) Process for the preparation of gefitiib
PT2146944E (pt) Processo para a preparação de folatos marcados com 18f
HK1126221A1 (en) Process for the preparation of pyrazolylaminoquinazoline derivatives comprising a phosphate group
PL2229062T3 (pl) Sposób wytwarzania hydrolizatu
EG25838A (en) Process for the preparation of amino acid methyl esters
EP2170813A4 (de) Neues verfahren zur herstellung von pregabalin
IL196618A0 (en) A process for the preparation of lamotrigine
EP2046342A4 (de) Kristalline form a von ibandronsäure und herstellungsverfahren dafür
IL186294A0 (en) A process for the preparation of phenyltetrazole compounds
IL198603A0 (en) Process for the preparation of biphosphonic acids and salts thereof
AU2007270897A8 (en) Novel process for the preparation of bisphosphonic acids
IL208930A (en) A protein compound containing at least one indolesulfinyl group and a process for preparing the compound

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090212

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20110401

17Q First examination report despatched

Effective date: 20130221

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130704